BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 25, 2000
View Archived Issues
Scios reviews developments in third quarter
Read More
New developments at Elan during the third quarter
Read More
Brain distribution of KW-6002 examined in vitro and in vivo; metabolism in rats also studied
Read More
KMD-3213: binding kinetics and pharmacological activity correlated in vivo
Read More
Sanofi-Synthelabo recovers full rights to oxaliplatin for the U.S.
Read More
Bendamustine considered of little therapeutic value in heavily pretreated germ cell cancer
Read More
New market launch for Seroquel
Read More
Repligen's soluble form of CTLA4 cleared for phase II trials
Read More
ASA 2000: Ono-5046 protects against I/R-induced renal injury via effect on leukocyte activation
Read More
MGI Pharma selects pancreatic cancer as initial target in phase III trial of irofulven
Read More
Interaction of MCI-154 and isoflurane on myocardial contractility and hemodynamics
Read More
Bayer's Avelox approved in Canada
Read More
Two Nobex drug candidates to be supported by NIH grants
Read More
NIH grant to support Avant's herpes vaccine development
Read More
Cyclic tetrapeptide antitumor agents designed at Japan Energy
Read More
Medarex and ZymoGenetics unite to develop human antibodies
Read More
International patent issued recently for new CRF antagonists from Taisho
Read More
C&C describes new series of thrombin inhibitors
Read More
Researchers at Suntory present new nAChR agonists useful for CNS disorders
Read More
Novel dopamine D2 receptor agonists synthesized at AHP
Read More
EGF receptor tyrosine kinase inhibitors reported to be useful for PET imaging
Read More
Schering AG discloses new beta-carbolines useful in Rx of anxiety and cognition disorders
Read More
Delta opioid receptor ligands and potential therapeutic uses
Read More
Phase III trial of lupus drug LJP-394 begins
Read More
Ariad receives GVHD treatment patent
Read More
Cancer therapy activates multiple apoptosis pathways
Read More
